All In Biotech

Drug Trial Radar · NCT06706310

Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection

Evaluate TQ-A3334 Tablets Combined Nucleoside (Acid) Analogs in the Initial Treatment/Chronic Hepatitis B Virus (HBV) Infection Subjects of Chronic HBV Infection

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 116 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

116

Actual

Start

Dec 4, 2024

Primary completion

Dec 7, 2025

Study completion Dec 2026

Sponsor

Sponsor type
Industry
First posted
Nov 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study uses random, double -blindness, placebo control, and phase multi -center test design. All subjects who meet the standards receive TQ-A3334 per tablet/placebo nucleoside (acid) analog. A total of 116 subjects are needed.

Conditions

  • Chronic Hepatitis B

Interventions

  • PlaceboDrug

    Placebo contains no active substance.

  • TQA3334 TabletDrug

    Inhibit viral replication.

  • Nucleoside (acid) analogs (NAs)Drug

    Inhibit viral replication.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. At 24 weeks, the changes in serum HBSAG relative to the baselineTime frame: Up to 24 weeks

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • The Third Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China

  • Hospital workers in Liuzhou

    Liuzhou, Guangxi, China

  • WuHan Jinyintan Hospital

    Wuhan, Hubei, China

  • The Second XIANGYA Hospital Of Central South University

    Changsha, Hunan, China

  • The Fifth People's Hospital of Wuxi (Affiliated Wuxi Fifth Hospital of Jiangnan University)

    Wuxi, Jiangsu, China

  • The first hospital of Jilin University

    Changchun, Jilin, China

  • The Sixth People's Hospital of Shenyang

    Shenyang, Liaoning, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, China

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China

  • First People's Hospital of Yunnan Province

    Kunming, Yunnan, China

  • Pu'er People's Hospital

    Pu'er, Yunnan, China

  • People's Hospital Of RuiAn City

    Rui’an, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.